Table 14.
Haematology and coagulation results of males. The average + SD is given. *, A,B indicates significant difference, p < 0.05. A significant difference was found between the control group and the medium and high dose. The platelet count of those two groups were raised compared to the control group. In addition to that, the medium dose group had a significantly higher platelet count than the low dose and high dose group.
| Group 1, Control | Group 2, 100 mg/kg/day UA | Group 3, 300 mg/kg/day UA | Group 4, 1000 mg/kg/day UA | |
|---|---|---|---|---|
| APTT | 14.57 ± 0.873 | 15.66 ± 1.372 | 15.25 ± 0.525 | 15.42 ± 1.391 |
| BASO | 0.011 ± 0.004 | 0.010 ± 0 | 0.012 ± 0.004 | 0.013 ± 0.005 |
| EOS | 0.136 ± 0.070 | 0.120 ± 0.035 | 0.102 ± 0.040 | 0.129 ± 0.032 |
| FIB | 2.132 ± 0.149 | 2.056 ± 0.347 | 2.130 ± 0.163 | 2.225 ± 0.158 |
| HCT | 0.474 ± 0.031 | 0.482 ± 0.017 | 0.478 ± 0.200 | 0.491 ± 0.026 |
| HGB | 162.8 ± 6.923 | 164.1 ± 6.194 | 162.8 ± 3.584 | 165.3 ± 6.519 |
| LUC | 0.039 ± 0.027 | 0.041 ± 0.011 | 0.044 ± 0.016 | 0.043 ± 0.010 |
| LYMPH | 4.246 ± 0.938 | 4.778 ± 0.588 | 4.319 ± 0.969 | 4.211 ± 0.694 |
| MCH | 18.11 ± 0.494 | 17.69 ± 0.987 | 17.58 ± 0.991 | 17.42 ± 0.845 |
| MCHC | 344.0 ± 9.366 | 340.7 ± 9.734 | 340.6 ± 9.652 | 337.1 ± 8.580 |
| MCV | 52.68 ± 0.851 | 51.89 ± 1.668 | 51.57 ± 1.746 | 51.70 ± 2.061 |
| MONO | 0.086 ± 0.029 | 0.110 ± 0.041 | 0.097 ± 0.035 | 0.110 ± 0.034 |
| NEUT | 0.898 ± 0.191 | 0.938 ± 0.228 | 0.790 ± 0.247 | 1.024 ± 0.182 |
| PLT | 712.5 ± 91.06* | 726.0 ± 115.5A | 829.6 ± 76.56*A,B | 770.0 ± 292.6*,B |
| PT | 10.36 ± 0.260 | 10.38 ± 0.399 | 10.33 ± 0.241 | 10.28 ± 0.273 |
| RBC | 8.994 ± 0.543 | 9.294 ± 0.364 | 9.299 ± 0.638 | 9.819 ± 1.097 |
| RDWG | 12.24 ± 0.307 | 12.61 ± 0.411 | 12.80 ± 0.707 | 27.79 ± 45.18 |
| RETIC | 169.5 ± 15.69 | 163.9 ± 16.14 | 167.1 ± 19.66 | 154.9 ± 60.61 |
| WBC | 5.413 ± 1.170 | 5.990 ± 0.466 | 5.361 ± 1.074 | 5.609 ± 0.758 |